
Intuitive Surgical (ISRG) Stock
Intuitive Surgical Chart
Company Profile
Price: $588.81
Market Cap: $210.00B
Exchange: NASDAQ
CEO: Dr. Gary S. Guthart Ph.D.
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Employees: 13.68K
Headquarters: Sunnyvale, CA
Website: Intuitive Surgical
Business Summary
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Intuitive Surgical News
If You'd Invested $10,000 in Intuitive Surgical Stock 10 Years Ago, Here's How Much You'd Have Today
Many of us occasionally look at an impressive stock that we don't own and wonder, "How much would I have today if I'd invested in it some years ago?" One company that those in the know might wonder about is Intuitive Surgical (ISRG -0.15%) -- a giant in the robotic surgery arena.

Intuitive Surgical Just Posted a Solid Quarter, but This Is Why the Stock Could Be in Trouble This Year
Intuitive Surgical (ISRG 1.94%) should arguably be doing a whole lot better after coming off the release of some strong earnings numbers. Business is doing well, the growth rate is solid, and in the long run, the company has a lot of potential.

Is Intuitive Surgical Stock a Buy?
Intuitive Surgical (ISRG 1.30%) capped off a record-breaking 2024 with a blowout fourth-quarter earnings report. For the period ended Dec. 31, the medical technologies (medtech) giant delivered adjusted earnings per share (EPS) of $2.21, well above the $1.79 consensus Wall Street estimate.

Buy, Sell, Or Hold ISRG Stock At $585?
Intuitive Surgical (NASDAQ: ISRG) recently reported its Q4 results, with revenues and earnings exceeding the street estimates. The company reported revenue of $2.4 billion and adjusted earnings of $2.21 per share, compared to the consensus estimates of $2.2 billion and $1.79, respectively.

Intuitive Announces $45 Million Donation to the Intuitive Foundation to Promote Health and Advance Education
SUNNYVALE, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced a $45 million gift to the Intuitive Foundation that will be used to support the Foundation's mission of reducing the global burden of disease and suffering through philanthropy, research, and education aimed at better outcomes for patients everywhere.

Why Intuitive Surgical Stock Was Pulling Back Today
Shares of Intuitive Surgical (ISRG -3.67%) were pulling back today as a strong fourth-quarter earnings report didn't seem to be enough to justify the medical device maker's lofty valuation. Its guidance for 2025 was also slightly below estimates, which can often trigger a sell-off for growth stocks.

Intuitive Surgical, Inc. (ISRG) Q4 2024 Earnings Call Transcript
Intuitive Surgical, Inc. (NASDAQ:ISRG ) Q4 2024 Earnings Conference Call January 23, 2025 4:30 PM ET Company Participants Brandon Lamm - IR Gary Guthart - CEO Jamie Samath - CFO Daniel Oh - Senior Medical Officer Conference Call Participants Larry Biegelsen - Wells Fargo Robbie Marcus - JPMorgan Travis Steed - Bank of America Securities Rick Wise - Stifel David Roman - Goldman Sachs Patrick Wood - Morgan Stanley Operator Good day and thank you for standing by. Welcome to the Q4 2024 Intuitive Earnings Conference Call.

Intuitive Surgical (ISRG) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Intuitive Surgical (ISRG) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Robotic Surgery Titan Intuitive Surgical Slips On Conservative, But Expected, Guidance
Intuitive Surgical stock skidded late Thursday despite beating profit expectations following a strong sales preannouncement that sent shares on a sprint. The post Robotic Surgery Titan Intuitive Surgical Slips On Conservative, But Expected, Guidance appeared first on Investor's Business Daily.

Intuitive Announces Fourth Quarter Earnings
SUNNYVALE, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2024.

My Top 5 Stocks to Buy in Early 2025
It's the start of a new year, and that makes now the perfect time to load up on stocks that could boost your portfolio in 2025 and over the long term. The healthcare space is a great place to look for these sorts of players because here you'll find all that you need to gain in both growth and security -- from young biotechs developing game-changing technologies to big pharma or medical device players selling blockbuster drugs and paying out dividends to investors.

Intuitive Surgical Earnings
This section highlights Intuitive Surgical's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
---|---|---|---|---|---|
Read Transcript | Q4 | 2024 | 2025-01-23 | $1.76 | $2.21 |
Read Transcript | Q3 | 2024 | 2024-10-17 | $1.63 | $1.84 |
Read Transcript | Q2 | 2024 | 2024-07-18 | $1.54 | $1.78 |
Read Transcript | Q1 | 2024 | 2024-04-18 | $1.41 | $1.50 |
Read Transcript | Q4 | 2023 | 2024-01-23 | $1.48 | $1.60 |
Read Transcript | Q3 | 2023 | 2023-10-19 | $1.41 | $1.46 |
Read Transcript | Q2 | 2023 | 2023-07-20 | $1.33 | $1.42 |
Read Transcript | Q1 | 2023 | 2023-04-18 | $1.20 | $1.23 |
Financial Statements
Access annual & quarterly financial statements for Intuitive Surgical, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
---|---|---|---|---|---|
Revenue | $8.35B | $7.12B | $6.22B | $5.71B | $4.36B |
Cost of Revenue | $2.72B | $2.39B | $2.03B | $1.75B | $1.50B |
Gross Profit | $5.63B | $4.73B | $4.20B | $3.96B | $2.86B |
Gross Profit Ratio | 67.46% | 66.39% | 67.44% | 69.32% | 65.65% |
Research and Development Expenses | $1.15B | $998.80M | $879.00M | $671.00M | $595.10M |
General and Administrative Expenses | $- | $- | $- | $- | $- |
Selling and Marketing Expenses | $- | $- | $- | $- | $- |
Selling General and Administrative Expenses | $2.14B | $1.96B | $1.74B | $1.47B | $1.22B |
Other Expenses | $- | $- | $- | $- | $- |
Operating Expenses | $3.29B | $2.96B | $2.62B | $2.14B | $1.81B |
Cost and Expenses | $-6.00B | $5.36B | $4.65B | $3.89B | $3.31B |
Interest Income | $324.90M | $192.10M | $29.70M | $69.30M | $157.20M |
Interest Expense | $- | $- | $29.70M | $- | $- |
Depreciation and Amortization | $324.90M | $421.80M | $380.40M | $317.00M | $282.50M |
EBITDA | $2.67B | $2.17B | $1.94B | $2.13B | $1.33B |
EBITDA Ratio | 32.01% | 30.45% | 25.35% | 31.89% | 24.09% |
Operating Income | $2.35B | $1.77B | $1.21B | $1.82B | $773.60M |
Operating Income Ratio | 28.12% | 24.80% | 19.47% | 31.89% | 17.75% |
Total Other Income Expenses Net | $324.90M | $192.10M | $29.70M | $69.30M | $157.20M |
Income Before Tax | $2.67B | $1.96B | $1.61B | $1.89B | $1.21B |
Income Before Tax Ratio | 32.01% | 27.50% | 25.82% | 33.10% | 27.69% |
Income Tax Expense | $336.30M | $141.60M | $262.40M | $162.20M | $140.20M |
Net Income | $2.32B | $1.80B | $1.32B | $1.70B | $1.06B |
Net Income Ratio | 27.81% | 25.24% | 21.25% | 29.85% | 24.33% |
EPS | $6.54 | $5.12 | $3.72 | $4.79 | $3.02 |
EPS Diluted | $6.42 | $5.03 | $3.65 | $4.66 | $2.94 |
Weighted Average Shares Outstanding | 355.20M | 351.20M | 355.70M | 356.10M | 351.00M |
Weighted Average Shares Outstanding Diluted | 362.00M | 357.40M | 362.00M | 365.80M | 360.90M |
SEC Filing | Source | Source | Source | Source | Source |
Income Statement Charts
Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $2.41B | $2.04B | $2.01B | $1.89B | $1.93B | $1.74B | $1.76B | $1.70B | $1.66B | $1.56B | $1.52B | $1.49B | $1.55B | $1.40B | $1.46B | $1.29B | $1.33B | $1.08B | $852.10M | $1.10B |
Cost of Revenue | $771.30M | $664.20M | $637.20M | $645.20M | $650.90M | $576.50M | $584.00M | $583.20M | $544.10M | $505.30M | $498.80M | $478.00M | $489.90M | $431.90M | $440.30M | $389.50M | $433.30M | $353.40M | $349.20M | $361.30M |
Gross Profit | $1.64B | $1.37B | $1.37B | $1.25B | $1.28B | $1.17B | $1.17B | $1.11B | $1.11B | $1.05B | $1.02B | $1.01B | $1.06B | $971.40M | $1.02B | $902.60M | $895.80M | $724.30M | $502.90M | $738.20M |
Gross Profit Ratio | 68.04% | 67.41% | 68.30% | 65.87% | 66.24% | 66.94% | 66.74% | 65.62% | 67.12% | 67.55% | 67.23% | 67.87% | 68.41% | 69.22% | 69.92% | 69.86% | 67.40% | 67.21% | 59.02% | 67.14% |
Research and Development Expenses | $294.70M | $286.00M | $280.10M | $284.50M | $260.10M | $249.40M | $244.40M | $244.90M | $244.10M | $217.10M | $207.30M | $210.50M | $183.40M | $165.50M | $162.30M | $159.80M | $149.80M | $155.00M | $143.20M | $147.10M |
General and Administrative Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $308.10M | $- | $- | $308.10M |
Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $22.10M | $- | $- | $- |
Selling General and Administrative Expenses | $612.60M | $510.60M | $525.30M | $491.50M | $567.10M | $452.00M | $464.30M | $480.50M | $494.30M | $436.10M | $418.40M | $391.10M | $427.00M | $363.30M | $350.20M | $326.00M | $330.20M | $298.90M | $279.10M | $308.10M |
Other Expenses | $- | $- | $-0.00B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Operating Expenses | $907.30M | $796.60M | $805.40M | $776.00M | $827.20M | $701.40M | $708.70M | $725.40M | $738.40M | $653.20M | $625.70M | $601.60M | $610.40M | $528.80M | $512.50M | $485.80M | $480.00M | $453.90M | $422.30M | $455.20M |
Cost and Expenses | $-1.68B | $1.46B | $1.44B | $1.42B | $1.48B | $1.28B | $1.29B | $1.31B | $1.28B | $1.16B | $1.12B | $1.08B | $1.10B | $960.70M | $952.80M | $875.30M | $913.30M | $807.30M | $771.50M | $816.50M |
Interest Income | $74.90M | $- | $87.20M | $- | $92.50M | $45.80M | $36.00M | $37.90M | $22.20M | $3.90M | $9.30M | $- | $- | $- | $- | $32.00M | $20.70M | $- | $- | $- |
Interest Expense | $- | $- | $- | $- | $28.70M | $- | $- | $- | $22.20M | $3.90M | $9.30M | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Depreciation and Amortization | $74.90M | $116.20M | $111.80M | $109.30M | $114.00M | $108.60M | $97.30M | $92.70M | $112.10M | $89.80M | $86.00M | $83.80M | $83.20M | $82.10M | $78.90M | $71.70M | $79.80M | $69.20M | $63.80M | $63.40M |
EBITDA | $809.80M | $693.50M | $679.10M | $578.70M | $553.80M | $574.40M | $560.50M | $480.30M | $506.80M | $488.70M | $483.60M | $491.90M | $528.50M | $524.60M | $586.80M | $488.50M | $490.20M | $339.60M | $144.40M | $346.40M |
EBITDA Ratio | 33.55% | 34.03% | 33.79% | 30.61% | 29.74% | 32.94% | 26.38% | 22.85% | 22.51% | 25.61% | 26.12% | 27.43% | 29.04% | 31.54% | 34.92% | 32.26% | 31.28% | 25.09% | 9.46% | 25.74% |
Operating Income | $734.90M | $577.30M | $567.30M | $469.40M | $450.20M | $465.80M | $365.90M | $294.90M | $266.30M | $309.10M | $311.60M | $324.30M | $450.40M | $442.60M | $511.20M | $416.80M | $415.80M | $270.40M | $80.60M | $283.00M |
Operating Income Ratio | 30.45% | 28.33% | 28.23% | 24.83% | 23.35% | 26.71% | 20.84% | 17.39% | 16.09% | 19.85% | 20.47% | 21.80% | 29.04% | 31.54% | 34.92% | 32.26% | 31.28% | 25.09% | 9.46% | 25.74% |
Total Other Income Expenses Net | $74.90M | $93.70M | $87.20M | $69.10M | $65.70M | $56.20M | $36.00M | $34.20M | $22.20M | $3.90M | $9.30M | $-5.70M | $3.80M | $18.50M | $15.00M | $32.00M | $20.70M | $84.80M | $26.60M | $25.10M |
Income Before Tax | $809.80M | $671.00M | $654.50M | $538.50M | $515.90M | $522.00M | $499.20M | $421.80M | $394.70M | $402.80M | $406.90M | $402.40M | $454.20M | $461.10M | $526.20M | $448.80M | $436.50M | $355.20M | $107.20M | $308.10M |
Income Before Tax Ratio | 33.55% | 32.92% | 32.56% | 28.48% | 26.75% | 29.94% | 28.43% | 24.87% | 23.85% | 25.86% | 26.73% | 27.05% | 29.29% | 32.86% | 35.94% | 34.73% | 32.84% | 32.96% | 12.58% | 28.02% |
Income Tax Expense | $121.80M | $100.40M | $123.00M | $-8.90M | $-94.80M | $102.20M | $73.20M | $61.00M | $58.00M | $78.10M | $93.30M | $33.00M | $71.50M | $73.90M | $3.20M | $13.60M | $72.90M | $38.40M | $37.00M | $-8.10M |
Net Income | $685.70M | $565.10M | $526.90M | $544.90M | $606.20M | $415.70M | $420.80M | $355.30M | $324.90M | $324.00M | $307.80M | $365.60M | $380.60M | $380.50M | $517.20M | $426.30M | $365.20M | $313.90M | $68.00M | $313.50M |
Net Income Ratio | 28.41% | 27.73% | 26.22% | 28.82% | 31.44% | 23.84% | 23.96% | 20.95% | 19.63% | 20.80% | 20.22% | 24.57% | 24.54% | 27.11% | 35.33% | 32.99% | 27.48% | 29.13% | 7.98% | 28.51% |
EPS | $1.92 | $1.59 | $1.48 | $1.54 | $1.72 | $1.18 | $1.20 | $1.01 | $0.93 | $0.91 | $0.86 | $1.02 | $1.06 | $1.07 | $1.45 | $3.61 | $1.04 | $0.89 | $0.19 | $0.90 |
EPS Diluted | $1.88 | $1.56 | $1.46 | $1.51 | $1.69 | $1.16 | $1.18 | $1.00 | $0.91 | $0.90 | $0.85 | $1.00 | $1.04 | $1.04 | $1.42 | $3.51 | $1.01 | $0.87 | $0.19 | $0.87 |
Weighted Average Shares Outstanding | 356.40M | 355.80M | 355.00M | 353.50M | 352.10M | 351.70M | 350.90M | 350.20M | 351.10M | 355.30M | 358.10M | 358.40M | 357.50M | 356.80M | 355.80M | 353.40M | 352.80M | 351.90M | 350.40M | 349.20M |
Weighted Average Shares Outstanding Diluted | 363.90M | 362.70M | 361.00M | 360.50M | 358.20M | 358.20M | 357.30M | 356.00M | 357.00M | 360.50M | 363.90M | 366.70M | 367.40M | 366.80M | 364.80M | 362.85M | 363.30M | 361.80M | 359.10M | 359.40M |
SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
---|---|---|---|---|---|
Cash and Cash Equivalents | $2.03B | $2.75B | $1.58B | $1.29B | $1.62B |
Short Term Investments | $1.99B | $2.47B | $2.54B | $2.94B | $3.55B |
Cash and Short Term Investments | $4.01B | $5.22B | $6.74B | $8.62B | $6.87B |
Net Receivables | $1.36B | $1.27B | $1.07B | $893.00M | $645.50M |
Inventory | $1.49B | $1.22B | $893.20M | $587.10M | $601.50M |
Other Current Assets | $253.70M | $176.70M | $168.60M | $133.90M | $393.80M |
Total Current Assets | $7.11B | $7.89B | $8.58B | $9.99B | $8.12B |
Property Plant Equipment Net | $4.65B | $3.54B | $2.37B | $1.88B | $1.58B |
Goodwill | $347.50M | $348.70M | $348.50M | $343.60M | $336.70M |
Intangible Assets | $23.00M | $39.10M | $49.80M | $70.50M | $77.40M |
Goodwill and Intangible Assets | $370.50M | $387.80M | $348.50M | $343.60M | $336.70M |
Long Term Investments | $4.82B | $2.12B | $2.62B | $4.42B | $1.76B |
Tax Assets | $1.05B | $910.50M | $664.60M | $441.40M | $367.70M |
Other Non-Current Assets | $750.90M | $597.60M | $-1.61B | $-3.51B | $-986.60M |
Total Non-Current Assets | $11.63B | $7.55B | $4.40B | $3.57B | $3.05B |
Other Assets | $- | $- | $- | $- | $- |
Total Assets | $18.74B | $15.44B | $12.97B | $13.55B | $11.17B |
Account Payables | $193.40M | $188.70M | $147.00M | $121.20M | $81.60M |
Short Term Debt | $- | $- | $- | $20.40M | $- |
Tax Payables | $154.40M | $111.40M | $96.10M | $54.10M | $47.20M |
Deferred Revenue | $468.80M | $446.10M | $438.30M | $414.00M | $382.40M |
Other Current Liabilities | $928.70M | $912.50M | $781.70M | $576.90M | $486.10M |
Total Current Liabilities | $1.75B | $1.66B | $1.86B | $1.60B | $1.41B |
Long Term Debt | $- | $64.50M | $69.60M | $66.60M | $58.00M |
Deferred Revenue Non-Current | $- | $45.60M | $41.00M | $36.80M | $32.10M |
Deferred Tax Liabilities Non-Current | $- | $- | $-69.60M | $- | $81.00M |
Other Non-Current Liabilities | $468.30M | $275.40M | $328.70M | $350.30M | $354.50M |
Total Non-Current Liabilities | $468.30M | $385.50M | $439.30M | $224.10M | $139.00M |
Other Liabilities | $- | $-0.00B | $-439.30M | $-224.10M | $-139.00M |
Total Liabilities | $2.21B | $2.04B | $1.86B | $1.60B | $1.41B |
Preferred Stock | $- | $- | $- | $- | $- |
Common Stock | $400.00K | $400.00K | $400.00K | $400.00K | $100.00K |
Retained Earnings | $6.80B | $4.74B | $3.50B | $4.76B | $3.26B |
Accumulated Other Comprehensive Income Loss | $-51.30M | $-12.20M | $-162.50M | $-24.20M | $24.90M |
Other Total Stockholders Equity | $9.68B | $8.58B | $7.70B | $7.16B | $6.45B |
Total Stockholders Equity | $16.43B | $13.31B | $11.11B | $11.95B | $9.76B |
Total Equity | $16.53B | $13.40B | $11.18B | $12.00B | $9.79B |
Total Liabilities and Stockholders Equity | $18.74B | $15.44B | $12.97B | $13.55B | $11.17B |
Minority Interest | $95.90M | $89.70M | $70.70M | $50.40M | $27.60M |
Total Liabilities and Total Equity | $18.74B | $15.44B | $12.97B | $13.55B | $11.17B |
Total Investments | $6.80B | $4.59B | $5.16B | $7.36B | $5.31B |
Total Debt | $- | $89.80M | $93.80M | $87.00M | $79.90M |
Net Debt | $-2.03B | $-2.66B | $-1.49B | $-1.20B | $-1.54B |
Balance Sheet Charts
Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $2.03B | $2.41B | $3.04B | $2.84B | $2.75B | $3.60B | $3.44B | $371.40M | $1.58B | $1.54B | $1.54B | $1.10B | $1.29B | $1.35B | $1.62B | $1.40B | $1.62B | $1.37B | $2.04B | $1.22B |
Short Term Investments | $1.99B | $1.82B | $1.72B | $1.96B | $2.47B | $2.87B | $2.36B | $2.55B | $2.54B | $2.78B | $2.91B | $2.89B | $2.94B | $2.79B | $2.82B | $3.16B | $3.55B | $3.35B | $2.45B | $2.03B |
Cash and Short Term Investments | $4.01B | $4.23B | $4.76B | $4.80B | $5.22B | $6.48B | $7.13B | $6.58B | $6.74B | $7.39B | $8.18B | $8.40B | $8.62B | $8.22B | $7.73B | $7.23B | $6.87B | $6.36B | $6.07B | $5.90B |
Net Receivables | $1.36B | $1.29B | $1.24B | $1.26B | $1.27B | $1.10B | $1.04B | $1.06B | $1.07B | $971.10M | $955.00M | $1.02B | $893.00M | $793.60M | $794.30M | $733.30M | $645.50M | $588.60M | $508.80M | $527.60M |
Inventory | $1.49B | $1.48B | $1.38B | $1.30B | $1.22B | $1.15B | $1.01B | $946.60M | $893.20M | $837.10M | $724.00M | $653.00M | $587.10M | $584.90M | $569.70M | $576.80M | $601.50M | $662.90M | $645.50M | $620.30M |
Other Current Assets | $253.70M | $212.20M | $270.00M | $272.90M | $176.70M | $- | $188.60M | $- | $168.60M | $165.90M | $167.50M | $138.60M | $133.90M | $217.50M | $213.40M | $198.80M | $267.50M | $330.60M | $258.80M | $502.00M |
Total Current Assets | $7.11B | $7.22B | $7.65B | $7.63B | $7.89B | $8.90B | $9.04B | $8.45B | $8.58B | $9.08B | $9.74B | $9.96B | $9.99B | $9.50B | $9.00B | $8.46B | $8.12B | $7.61B | $7.59B | $7.41B |
Property Plant Equipment Net | $4.65B | $4.43B | $4.12B | $3.80B | $3.54B | $3.08B | $2.83B | $2.58B | $2.37B | $2.24B | $2.11B | $1.97B | $1.88B | $1.74B | $1.65B | $1.59B | $1.58B | $1.51B | $1.45B | $1.37B |
Goodwill | $347.50M | $348.30M | $348.00M | $348.20M | $348.70M | $348.10M | $348.60M | $348.60M | $348.50M | $348.20M | $349.10M | $343.20M | $343.60M | $344.30M | $344.30M | $344.50M | $336.70M | $336.30M | $336.80M | $335.00M |
Intangible Assets | $23.00M | $25.30M | $28.70M | $33.80M | $636.70M | $638.40M | $693.10M | $5.00M | $49.80M | $57.10M | $66.20M | $64.10M | $70.50M | $77.20M | $84.00M | $87.20M | $77.40M | $88.90M | $101.00M | $488.00M |
Goodwill and Intangible Assets | $370.50M | $373.60M | $376.70M | $382.00M | $985.40M | $986.50M | $348.60M | $348.60M | $348.50M | $348.20M | $349.10M | $343.20M | $343.60M | $344.30M | $344.30M | $344.50M | $336.70M | $336.30M | $336.80M | $335.00M |
Long Term Investments | $4.82B | $4.08B | $3.14B | $2.73B | $2.12B | $1.04B | $1.33B | $1.89B | $2.62B | $3.08B | $3.74B | $4.42B | $4.42B | $4.13B | $3.30B | $2.67B | $1.76B | $1.64B | $1.59B | $2.64B |
Tax Assets | $1.05B | $997.00M | $946.90M | $917.80M | $910.50M | $701.40M | $666.50M | $644.70M | $664.60M | $587.40M | $515.90M | $485.40M | $441.40M | $411.50M | $394.40M | $336.60M | $367.70M | $360.30M | $365.50M | $364.70M |
Other Non-Current Assets | $750.90M | $644.40M | $412.40M | $364.00M | $- | $- | $-316.20M | $-857.20M | $-1.61B | $-2.08B | $-2.75B | $-3.50B | $-3.51B | $-3.19B | $-2.39B | $-1.87B | $-986.60M | $-844.90M | $-1.23B | $-2.23B |
Total Non-Current Assets | $11.63B | $10.53B | $9.00B | $8.20B | $7.55B | $5.81B | $4.86B | $4.60B | $4.40B | $4.18B | $3.97B | $3.72B | $3.57B | $3.44B | $3.29B | $3.08B | $3.05B | $3.00B | $2.51B | $2.48B |
Other Assets | $- | $- | $- | $-0.00B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Assets | $18.74B | $17.74B | $16.65B | $15.83B | $15.44B | $14.71B | $13.90B | $13.05B | $12.97B | $13.26B | $13.71B | $13.68B | $13.55B | $12.93B | $12.30B | $11.54B | $11.17B | $10.62B | $10.10B | $9.89B |
Account Payables | $193.40M | $218.70M | $194.40M | $194.40M | $188.70M | $196.20M | $199.70M | $164.10M | $147.00M | $164.20M | $149.70M | $128.10M | $121.20M | $120.00M | $117.90M | $103.10M | $81.60M | $116.00M | $108.90M | $133.40M |
Short Term Debt | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $20.40M | $- | $- | $- | $- | $- | $- | $- |
Tax Payables | $154.40M | $164.60M | $85.90M | $51.80M | $111.40M | $342.80M | $230.20M | $125.40M | $96.10M | $71.20M | $40.80M | $113.30M | $54.10M | $65.90M | $58.80M | $50.70M | $47.20M | $35.30M | $37.70M | $34.60M |
Deferred Revenue | $468.80M | $426.00M | $433.90M | $437.50M | $446.10M | $394.80M | $450.60M | $462.50M | $438.30M | $395.60M | $413.70M | $424.40M | $414.00M | $383.50M | $392.00M | $389.20M | $382.40M | $358.10M | $371.50M | $366.20M |
Other Current Liabilities | $928.70M | $867.50M | $773.30M | $691.40M | $912.50M | $742.60M | $703.30M | $600.10M | $781.70M | $639.10M | $608.20M | $484.80M | $576.90M | $492.90M | $467.90M | $392.70M | $486.10M | $415.60M | $435.10M | $440.50M |
Total Current Liabilities | $1.75B | $1.68B | $1.49B | $1.38B | $1.66B | $1.68B | $1.94B | $1.76B | $1.86B | $1.69B | $1.62B | $1.52B | $1.60B | $1.48B | $1.42B | $1.35B | $1.41B | $1.33B | $1.34B | $1.36B |
Long Term Debt | $- | $- | $- | $- | $64.50M | $- | $- | $- | $69.60M | $- | $- | $- | $66.60M | $- | $- | $- | $58.00M | $- | $- | $- |
Deferred Revenue Non-Current | $54.10M | $59.60M | $43.50M | $50.20M | $45.60M | $42.50M | $45.40M | $44.70M | $41.00M | $36.70M | $37.40M | $38.40M | $36.80M | $35.00M | $32.00M | $31.10M | $32.10M | $30.30M | $28.40M | $28.80M |
Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $82.10M | $- | $- | $- | $-69.60M | $- | $- | $- | $229.60M | $- | $- | $- | $-58.00M | $- | $- | $- |
Other Non-Current Liabilities | $414.20M | $329.50M | $322.40M | $356.30M | $275.40M | $370.30M | $359.80M | $406.90M | $328.70M | $416.70M | $410.40M | $370.90M | $350.30M | $412.80M | $380.90M | $414.50M | $354.50M | $405.80M | $384.00M | $385.90M |
Total Non-Current Liabilities | $468.30M | $389.10M | $365.90M | $406.50M | $385.50M | $412.80M | $405.20M | $462.50M | $439.30M | $453.40M | $447.80M | $409.30M | $453.70M | $447.80M | $412.90M | $445.60M | $444.60M | $436.10M | $412.40M | $414.70M |
Other Liabilities | $- | $- | $- | $- | $- | $- | $-405.20M | $-462.50M | $-439.30M | $-453.40M | $-447.80M | $-409.30M | $-453.70M | $-447.80M | $-412.90M | $-445.60M | $-444.60M | $-436.10M | $-412.40M | $-414.70M |
Total Liabilities | $2.21B | $2.07B | $1.85B | $1.78B | $2.04B | $2.09B | $1.94B | $1.76B | $1.86B | $1.69B | $1.62B | $1.52B | $1.60B | $1.48B | $1.42B | $1.35B | $1.41B | $1.33B | $1.34B | $1.36B |
Preferred Stock | $- | $- | $- | $- | $- | $- | $80.60M | $- | $- | $- | $- | $- | $50.40M | $48.60M | $42.00M | $36.70M | $27.60M | $28.90M | $25.90M | $23.80M |
Common Stock | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $100.00K | $100.00K | $100.00K | $100.00K | $100.00K | $100.00K |
Retained Earnings | $6.80B | $6.13B | $5.58B | $5.07B | $4.74B | $4.21B | $3.81B | $3.40B | $3.50B | $4.02B | $4.68B | $4.86B | $4.76B | $4.39B | $4.02B | $3.51B | $3.26B | $2.94B | $2.63B | $2.57B |
Accumulated Other Comprehensive Income Loss | $-51.30M | $12.90M | $-23.50M | $-8.70M | $-12.20M | $-56.50M | $-79.80M | $-108.50M | $-162.50M | $-187.60M | $-144.20M | $-110.70M | $-24.20M | $5.30M | $10.30M | $11.40M | $24.90M | $16.20M | $22.30M | $8.90M |
Other Total Stockholders Equity | $9.68B | $9.44B | $9.15B | $8.90B | $8.58B | $8.39B | $8.15B | $7.93B | $7.70B | $7.68B | $7.48B | $7.35B | $7.16B | $7.02B | $6.80B | $6.63B | $6.45B | $6.30B | $6.09B | $5.93B |
Total Stockholders Equity | $16.43B | $15.58B | $14.71B | $13.96B | $13.31B | $12.54B | $11.96B | $11.29B | $11.11B | $11.57B | $12.08B | $12.16B | $11.95B | $11.46B | $10.88B | $10.19B | $9.76B | $9.29B | $8.77B | $8.53B |
Total Equity | $16.53B | $15.68B | $14.80B | $14.05B | $13.40B | $12.62B | $12.04B | $11.37B | $11.18B | $11.63B | $12.14B | $12.21B | $12.00B | $11.51B | $10.92B | $10.23B | $9.79B | $9.32B | $8.79B | $8.55B |
Total Liabilities and Stockholders Equity | $18.74B | $17.74B | $16.65B | $15.83B | $15.44B | $14.71B | $13.90B | $13.05B | $12.97B | $13.26B | $13.71B | $13.68B | $13.55B | $12.93B | $12.30B | $11.54B | $11.17B | $10.62B | $10.10B | $9.89B |
Minority Interest | $95.90M | $94.20M | $88.20M | $83.80M | $89.70M | $84.50M | $80.60M | $76.50M | $70.70M | $58.60M | $59.40M | $54.60M | $50.40M | $48.60M | $42.00M | $36.70M | $27.60M | $28.90M | $25.90M | $23.80M |
Total Liabilities and Total Equity | $18.74B | $17.74B | $16.65B | $15.83B | $15.44B | $14.71B | $13.90B | $13.05B | $12.97B | $13.26B | $13.71B | $13.68B | $13.55B | $12.93B | $12.30B | $11.54B | $11.17B | $10.62B | $10.10B | $9.89B |
Total Investments | $6.80B | $5.90B | $4.86B | $4.69B | $4.59B | $3.92B | $3.70B | $4.44B | $5.16B | $5.86B | $6.65B | $7.31B | $7.36B | $6.92B | $6.12B | $5.83B | $5.31B | $4.99B | $4.04B | $4.67B |
Total Debt | $- | $- | $- | $- | $89.80M | $- | $- | $- | $93.80M | $- | $- | $- | $87.00M | $- | $- | $- | $58.00M | $275.70M | $- | $- |
Net Debt | $-2.03B | $-2.41B | $-3.04B | $-2.84B | $-2.66B | $-3.60B | $-3.44B | $-371.40M | $-1.49B | $-1.54B | $-1.54B | $-1.10B | $-1.20B | $-1.35B | $-1.62B | $-1.40B | $-1.56B | $-1.09B | $-2.04B | $-1.22B |
Annual Cash Flow
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
---|---|---|---|---|---|
Net Income | $2.34B | $1.82B | $1.34B | $1.73B | $1.07B |
Depreciation and Amortization | $-26.60M | $435.20M | $365.80M | $310.20M | $276.20M |
Deferred Income Tax | $-135.30M | $-280.80M | $-185.30M | $-62.60M | $57.60M |
Stock Based Compensation | $676.80M | $598.20M | $513.20M | $449.20M | $395.40M |
Change in Working Capital | $- | $-777.60M | $-619.10M | $-368.10M | $-273.20M |
Accounts Receivables | $-95.90M | $-186.30M | $-159.30M | $-142.30M | $5.70M |
Inventory | $-830.00M | $-712.50M | $-546.60M | $-256.00M | $-170.10M |
Accounts Payables | $-400.00K | $41.70M | $21.30M | $36.00M | $-32.30M |
Other Working Capital | $- | $79.50M | $65.50M | $-5.80M | $-76.50M |
Other Non Cash Items | $-437.40M | $21.50M | $71.80M | $32.60M | $-38.00M |
Net Cash Provided by Operating Activities | $2.42B | $1.81B | $1.49B | $2.09B | $1.48B |
Investments in Property Plant and Equipment | $-1.11B | $-1.06B | $-532.40M | $-353.50M | $-341.50M |
Acquisitions Net | $- | $-8.90M | $-12.80M | $-8.70M | $-37.70M |
Purchases of Investments | $-5.14B | $-2.21B | $-1.40B | $-6.45B | $-4.29B |
Sales Maturities of Investments | $2.98B | $2.92B | $3.32B | $4.35B | $3.73B |
Other Investing Activities | $-1.00M | $- | $1.92B | $-2.10B | $-561.40M |
Net Cash Used for Investing Activities | $-3.27B | $-360.10M | $1.37B | $-2.46B | $-940.60M |
Debt Repayment | $- | $- | $- | $- | $- |
Common Stock Issued | $429.40M | $- | $233.80M | $276.50M | $308.80M |
Common Stock Repurchased | $- | $-416.30M | $-2.61B | $-211.60M | $-134.30M |
Dividends Paid | $-8.00M | $- | $- | $- | $- |
Other Financing Activities | $158.90M | $128.70M | $35.10M | $43.00M | $48.60M |
Net Cash Used Provided by Financing Activities | $150.90M | $-287.60M | $-2.57B | $43.00M | $-85.70M |
Effect of Forex Changes on Cash | $-800.00K | $3.30M | $5.40M | $-3.40M | $-2.60M |
Net Change in Cash | $-707.70M | $1.17B | $294.70M | $-332.50M | $455.90M |
Cash at End of Period | $2.06B | $2.77B | $1.60B | $1.31B | $1.64B |
Cash at Beginning of Period | $2.77B | $1.60B | $1.31B | $1.64B | $1.18B |
Operating Cash Flow | $2.42B | $1.81B | $1.49B | $2.09B | $1.48B |
Capital Expenditure | $-1.11B | $-1.06B | $-532.40M | $-353.50M | $-341.50M |
Free Cash Flow | $1.30B | $749.60M | $958.40M | $1.74B | $1.14B |
Cash Flow Charts
Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $688.00M | $570.60M | $526.90M | $544.90M | $610.70M | $419.80M | $426.00M | $360.80M | $336.70M | $324.70M | $313.60M | $369.40M | $382.70M | $387.20M | $523.00M | $435.20M | $363.60M | $316.80M | $70.20M | $316.20M |
Depreciation and Amortization | $124.70M | $116.20M | $111.80M | $109.30M | $123.20M | $108.60M | $97.30M | $92.70M | $106.20M | $89.80M | $86.00M | $83.80M | $80.90M | $82.00M | $75.60M | $71.70M | $79.80M | $69.20M | $63.80M | $63.40M |
Deferred Income Tax | $-30.80M | $-64.70M | $-32.60M | $-7.20M | $-219.80M | $-43.30M | $-27.00M | $9.30M | $-83.30M | $-61.90M | $-25.70M | $-14.40M | $-22.00M | $-16.60M | $-68.70M | $44.70M | $-14.30M | $19.40M | $-12.00M | $64.50M |
Stock Based Compensation | $177.00M | $172.90M | $173.60M | $153.30M | $150.40M | $156.10M | $146.50M | $139.80M | $127.60M | $138.10M | $126.70M | $120.80M | $117.80M | $120.10M | $108.10M | $103.20M | $103.10M | $105.80M | $95.90M | $90.60M |
Change in Working Capital | $-140.80M | $-85.60M | $-152.90M | $-540.00M | $-439.20M | $-100.80M | $5.90M | $-243.50M | $-60.80M | $-124.20M | $-68.70M | $-365.40M | $-10.90M | $-79.00M | $-108.70M | $-169.50M | $81.50M | $-179.00M | $10.50M | $-186.20M |
Accounts Receivables | $-74.10M | $-42.80M | $18.80M | $2.20M | $-166.60M | $-59.00M | $22.40M | $16.90M | $-92.10M | $-11.20M | $67.40M | $-123.40M | $-87.60M | $4.90M | $-45.30M | $-14.30M | $-51.50M | $-79.70M | $18.70M | $118.20M |
Inventory | $-179.10M | $-261.50M | $-209.80M | $-179.60M | $-184.30M | $-239.60M | $-161.50M | $-127.10M | $-127.50M | $-173.60M | $-125.40M | $-120.10M | $-66.80M | $-96.80M | $-51.20M | $-41.20M | $6.90M | $-56.90M | $-54.90M | $-65.20M |
Accounts Payables | $-21.60M | $22.80M | $5.90M | $-7.50M | $14.00M | $-8.80M | $19.60M | $16.90M | $-5.00M | $13.90M | $14.30M | $-1.90M | $200.00K | $-2.40M | $14.50M | $23.70M | $-28.40M | $-300.00K | $-25.50M | $21.90M |
Other Working Capital | $134.00M | $195.90M | $32.20M | $-355.10M | $-102.30M | $206.60M | $125.40M | $-150.20M | $163.80M | $46.70M | $-25.00M | $-120.00M | $143.30M | $15.30M | $-26.70M | $-137.70M | $154.50M | $-42.10M | $72.20M | $-261.10M |
Other Non Cash Items | $4.50M | $-2.90M | $576.00M | $335.30M | $3.00M | $8.00M | $17.00M | $12.30M | $11.50M | $16.70M | $14.80M | $28.80M | $19.20M | $7.70M | $13.40M | $-7.70M | $13.80M | $-57.60M | $1.50M | $4.30M |
Net Cash Provided by Operating Activities | $822.60M | $706.50M | $620.50M | $38.80M | $228.30M | $548.40M | $665.70M | $371.40M | $437.90M | $383.20M | $446.70M | $223.00M | $567.70M | $501.40M | $542.70M | $477.60M | $627.50M | $274.60M | $229.90M | $352.80M |
Investments in Property Plant and Equipment | $-312.00M | $-247.90M | $-309.40M | $-241.90M | $-435.50M | $-256.30M | $-178.30M | $-194.10M | $-137.70M | $-169.10M | $-130.50M | $-95.10M | $-150.90M | $-68.30M | $-75.70M | $-58.60M | $-61.90M | $-64.40M | $-110.00M | $-105.20M |
Acquisitions Net | $-1.00M | $113.40M | $- | $-113.40M | $-1.80M | $200.00K | $-7.30M | $-767.20M | $-1.20M | $200.00K | $-11.80M | $-1.50M | $-14.00M | $- | $- | $-8.70M | $-105.20M | $- | $- | $-37.70M |
Purchases of Investments | $-1.43B | $-1.92B | $-883.50M | $-905.90M | $-1.39B | $-806.20M | $-10.50M | $-3.50M | $-5.90M | $-17.40M | $-188.90M | $-1.19B | $-1.24B | $-1.71B | $-1.67B | $-1.83B | $-1.27B | $-1.60B | $-736.80M | $-690.00M |
Sales Maturities of Investments | $478.80M | $755.10M | $725.80M | $1.02B | $780.30M | $615.70M | $753.70M | $770.70M | $719.60M | $730.80M | $797.40M | $1.07B | $748.20M | $935.50M | $1.37B | $1.30B | $997.30M | $634.90M | $1.38B | $715.80M |
Other Investing Activities | $- | $-113.40M | $-157.70M | $113.40M | $-606.90M | $-190.50M | $743.20M | $767.20M | $713.70M | $713.40M | $608.50M | $-119.60M | $-490.10M | $-770.50M | $-309.00M | $-529.70M | $105.20M | $-961.50M | $646.70M | $25.80M |
Net Cash Used for Investing Activities | $-1.26B | $-1.41B | $-467.10M | $-128.50M | $-1.04B | $-446.60M | $557.60M | $573.10M | $574.80M | $544.50M | $466.20M | $-214.70M | $-641.00M | $-838.80M | $-384.70M | $-597.00M | $-334.30M | $-1.03B | $536.70M | $-117.10M |
Debt Repayment | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Common Stock Issued | $- | $115.60M | $71.50M | $180.40M | $44.10M | $77.40M | $74.60M | $100.20M | $- | $- | $- | $80.00M | $276.50M | $91.10M | $69.70M | $84.00M | $- | $- | $- | $91.30M |
Common Stock Repurchased | $- | $240.10M | $-13.50M | $-226.60M | $-66.30M | $-14.80M | $-10.90M | $-350.00M | $-1.00B | $-1.00B | $-500.10M | $-106.50M | $-10.40M | $-13.30M | $-9.60M | $- | $-34.30M | $-10.20M | $-6.20M | $-100.00M |
Dividends Paid | $- | $-8.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Financing Activities | $49.40M | $106.20M | $50.00M | $-46.70M | $78.90M | $61.80M | $63.30M | $-31.20M | $82.50M | $155.20M | $18.00M | $-93.40M | $18.60M | $68.30M | $58.30M | $-186.20M | $35.40M | $85.20M | $47.60M | $-78.70M |
Net Cash Used Provided by Financing Activities | $49.40M | $98.20M | $50.00M | $179.90M | $-31.50M | $61.80M | $63.30M | $-381.20M | $-963.50M | $-926.80M | $-482.10M | $-199.90M | $18.60M | $68.30M | $58.30M | $-102.20M | $-39.80M | $85.20M | $47.60M | $-178.70M |
Effect of Forex Changes on Cash | $8.30M | $-12.20M | $-3.70M | $6.80M | $-5.40M | $1.70M | $5.20M | $1.80M | $-2.50M | $1.90M | $2.20M | $3.80M | $-1.10M | $300.00K | $-3.40M | $800.00K | $-600.00K | $-400.00K | $-800.00K | $-800.00K |
Net Change in Cash | $-383.90M | $-590.40M | $197.20M | $89.40M | $-852.80M | $165.30M | $1.29B | $565.10M | $46.70M | $2.80M | $433.00M | $-187.80M | $-55.80M | $-268.80M | $212.90M | $-220.80M | $252.80M | $-666.50M | $813.40M | $56.20M |
Cash at End of Period | $2.06B | $2.45B | $3.04B | $2.84B | $2.77B | $3.62B | $3.46B | $2.17B | $1.60B | $1.55B | $1.55B | $1.12B | $1.31B | $1.36B | $1.63B | $1.42B | $1.64B | $1.39B | $2.05B | $1.24B |
Cash at Beginning of Period | $2.45B | $3.04B | $2.84B | $2.75B | $3.62B | $3.46B | $2.17B | $1.60B | $1.55B | $1.55B | $1.12B | $1.31B | $1.36B | $1.63B | $1.42B | $1.64B | $1.39B | $2.05B | $1.24B | $1.18B |
Operating Cash Flow | $822.60M | $706.50M | $620.50M | $38.80M | $228.30M | $548.40M | $665.70M | $371.40M | $437.90M | $383.20M | $446.70M | $223.00M | $567.70M | $501.40M | $542.70M | $477.60M | $627.50M | $274.60M | $229.90M | $352.80M |
Capital Expenditure | $-312.00M | $-247.90M | $-309.40M | $-241.90M | $-435.50M | $-256.30M | $-178.30M | $-194.10M | $-137.70M | $-169.10M | $-130.50M | $-95.10M | $-150.90M | $-68.30M | $-75.70M | $-58.60M | $-61.90M | $-64.40M | $-110.00M | $-105.20M |
Free Cash Flow | $510.60M | $458.60M | $311.10M | $-203.10M | $-207.20M | $292.10M | $487.40M | $177.30M | $300.20M | $214.10M | $316.20M | $127.90M | $416.80M | $433.10M | $467.00M | $419.00M | $565.60M | $210.20M | $119.90M | $247.60M |
Intuitive Surgical Stock Forecast
Analyst ratings, price targets, and earnings estimates for ISRG.
ISRG Analyst Ratings
Strong Buy
Based on 19 analysts in the past 3 months
ISRG Stock 12 Month Forecast
$645.00
Based on 2 analysts in the last 3 months
Recent Price Targets
Recommendation Trends
Analyst Estimates
Revenue Estimates
Net Income Estimates
EPS Estimates
Revenue Estimates
Net Income Estimates
EPS Estimates
Revenue Estimates
Net Income Estimates
EPS Estimates
Revenue Estimates
Net Income Estimates
EPS Estimates
Revenue Estimates
Net Income Estimates
EPS Estimates
Latest Price Target Updates
Date | Analyst | Firm | Price Target | Price When Posted | Upside |
---|---|---|---|---|---|
Dec 18, 2024 | Richard Newitter | Truist Financial | $640.00 | $526.47 | 21.6% |
Dec 02, 2024 | Patrick Wood | Morgan Stanley | $650.00 | $541.93 | 19.9% |
Oct 18, 2024 | David Roman | Goldman Sachs | $604.00 | $517.97 | 16.6% |
Oct 18, 2024 | Shagun Singh | RBC Capital | $555.00 | $473.73 | 17.2% |
Oct 18, 2024 | Adam Maeder | Piper Sandler | $538.00 | $473.73 | 13.6% |
Oct 18, 2024 | Anthony Petrone | Mizuho Securities | $550.00 | $473.73 | 16.1% |
Oct 18, 2024 | Rick Wise | Stifel Nicolaus | $525.00 | $473.73 | 10.8% |
Oct 18, 2024 | Richard Newitter | Truist Financial | $570.00 | $473.73 | 20.3% |
Oct 18, 2024 | Vijay Kumar | Evercore ISI | $490.00 | $473.73 | 3.4% |
Oct 18, 2024 | Ryan Zimmerman | BTIG | $535.00 | $473.73 | 12.9% |
Intuitive Surgical Dividends
Explore Intuitive Surgical's dividend history, including dividend yield, payout ratio, and historical payments.
Peers: Medical - Instruments & Supplies
This section provides companies within the same sector, on the same exchange, and of similar market capitalization, allowing comparisons of key financial indicators among peers.
Company | Market Cap | Price | EPS | P/E Ratio | P/B Ratio |
---|---|---|---|---|---|
![]() Repligen Corporation
RGEN
|
$8.96B | $160.00 | $0.64 | $281.45 | $5.08 |
![]() ResMed Inc.
RMD
|
$34.95B | $237.96 | $6.94 | $26.92 | $5.65 |
![]() Merit Medical Systems, Inc.
MMSI
|
$6.34B | $108.85 | $1.64 | $46.34 | $3.64 |
![]() ICU Medical, Inc.
ICUI
|
$3.87B | $158.13 | $-1.23 | $-81.03 | $1.13 |
![]() Bionano Genomics, Inc.
BNGO
|
$13.11M | $5.63 | $-6.81 | $-16.66 | $40.27 |
![]() Innovative Eyewear, Inc.
LUCY
|
$11.97M | $4.90 | $-12.67 | $-0.67 | $0.80 |
![]() Stereotaxis, Inc.
STXS
|
$211.74M | $2.50 | $-0.26 | $-6.82 | $6.44 |
![]() NEXGEL, Inc.
NXGL
|
$23.22M | $3.42 | $-0.56 | $-3.83 | $2.57 |
![]() Embecta Corp.
EMBC
|
$1.03B | $17.69 | $0.00 | $0.00 | $0.00 |
![]() Baxter International Inc.
BAX
|
$15.68B | $30.71 | $5.25 | $7.37 | $2.33 |
![]() West Pharmaceutical Services, Inc.
WST
|
$23.88B | $329.72 | $7.99 | $44.09 | $9.08 |
![]() The Cooper Companies, Inc.
COO
|
$18.94B | $94.90 | $1.97 | $53.07 | $2.58 |
![]() Teleflex Incorporated
TFX
|
$8.00B | $172.27 | $7.58 | $32.87 | $2.64 |
![]() Becton, Dickinson and Company
BDX
|
$66.40B | $228.97 | $5.88 | $40.97 | $2.70 |
![]() Hologic, Inc.
HOLX
|
$14.66B | $64.94 | $3.35 | $24.13 | $3.71 |
Related Metrics
Explore detailed financial metrics and analysis for ISRG.